Executives On The Move
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: AbbVie, FSD Pharma and More
Recent executive changes in the industry include C-suite changes at AbbVie and Pharnext. Meanwhile, new directors were appointed at Zydus Lifesciences and FSD Pharma.
Executives On The Move: Aerie Pharmaceuticals, Valeo Pharma and More
Recent executive changes in the industry include C-suite changes at ADC Therapeutics and ImmunoGen. Meanwhile, new directors were appointed at Aerie Pharmaceuticals and Adagene.
Executives On The Move: Sirnaomics, SIGA Technologies and More
Recent executive changes in the industry include C-suite changes at Sirnaomics and Horizon Therapeutics. Meanwhile, new directors were appointed at SIGA Technologies and Forte Biosciences.
Executives On The Move: Immune-Onc Therapeutics, Lipocine and More
Recent executive moves in the industry include C-suite changes at Lipocine and Actinium Pharmaceuticals. Meanwhile, new directors were appointed at Immune-Onc Therapeutics and Blue Water Vaccines.
Executives On The Move: Agile Therapeutics, Hikma Pharmaceuticals and More
Recent executive changes in the industry include C-suite changes at Agile Therapeutics and Orion Oyj. Meanwhile, new directors were appointed at Hikma Pharmaceuticals and Sigachi Industries.
Executives On The Move: Kaleo, Sagiment Biosciences and More
Recent executive changes in the industry include C-suite changes at Panaceutics Nutrition and Sagiment Biosciences. Meanwhile, new directors were appointed at Amarin Corp and Kaleo.
Executives On The Move: Dispersal Technologies, NeuBase Therapeutics and More
Recent executive moves in the industry include C-suite changes at NeuBase Therapeutics and Wave Life Sciences. Meanwhile, new directors were appointed at Dispersal Technologies and Forma Therapeutics.
Executives On The Move: Global Blood Therapeutics, Passage Bio and More
Recent executive changes in the industry include C-suite changes at Passage Bio and Neurelis. Meanwhile, new directors were appointed at Global Blood Therapeutics and Tarsus Pharmaceuticals.
Executives On The Move: Adhera Pharmaceuticals, Solid Biosciences and More
Recent executive changes in the industry include C-suite changes at Idera Pharmaceuticals, Adhera Therapeutics and Phio Pharmaceuticals. Meanwhile, new directors were appointed at Solid Biosciences and Sernova Corp.
Pivotal Period For Irlab And Its Parkinson’s Pipeline
The Swedish biotech is well positioned with soon-to-be late-stage clinical assets, commercial validation and a strong pipeline, new CEO Richard Godfrey tells Scrip.
Ex-Sanofi Partnering Chief Wants AI Start-Up Owkin To Be Industry Leader
Having led $30bn of acquisitions of companies at Sanofi, the new challenge for its former global head of partnering is to help make Owkin, “the most disruptive AI biotech company in the world,” he tells Scrip.
Executives On The Move: NervGen Pharma, Janux Therapeutics and More
Recent executive moves in the industry include C-suite changes at NervGen Pharma and Phathom Pharmaceuticals and Clarity Pharmaceuticals. Meanwhile, new directors were appointed at Janux Therapeutics and PepGen.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.